RPHM — Reneo Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $58.15m
- -$44.81m
- 10
- 43
- 13
- 11
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -12.4 | -19.5 | -39.8 | -52 | -77.4 |
Depreciation | |||||
Non-Cash Items | -1.67 | 0.378 | 4.54 | 3.55 | 1.32 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.56 | 0.514 | -2.8 | 0.959 | 12.2 |
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -12.5 | -18.5 | -38 | -47.4 | -63.7 |
Capital Expenditures | -0.007 | -0.024 | -0.198 | -0.346 | -0.221 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -7.23 | 7.4 | -23.2 | -57.5 | 10.7 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -7.24 | 7.38 | -23.4 | -57.8 | 10.5 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 25 | 47.3 | 132 | 0.471 | 60.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5.24 | 36.1 | 71 | -105 | 7.71 |